Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

AB SCIEX Announces Immunosuppressants Kit for Use by Doctors in Europe to Help Care for Organ Transplant Patients

Published: Friday, April 04, 2014
Last Updated: Friday, April 04, 2014
Bookmark and Share
The SCIEX IVD-MS™ Immunosuppressants kit is designed to give clinicians fast, accurate information about the level of immunosuppressant drug circulating in a patient’s body.

Every organ transplant patient in the world faces the potential danger of his/her body rejecting a new organ, such as a heart, kidney or liver.  Immunosuppressant drugs are required to help prevent rejection.  To help improve the monitoring of this life-saving drug therapy, AB Sciex Pte. Ltd. today announced an immunosuppressants kit for use by European doctors and hospitals.*  

Too little immunosuppressant could result in the body’s rejection of the new organ.  Too much could lead to toxic side-effects for the person.  Periodic monitoring of these patients, who usually have to take immunosuppressant drugs for the rest of their lives, is critically important. 

“AB Sciex is working to ensure the best in patient outcomes,” said Rainer Blair, President of AB Sciex.  “By making it easier for doctors and clinical laboratories to adopt this assay for immunosuppressant drug monitoring, we are able to improve the results that so directly impact patients’ lives.  Our new immunosuppressants kit will help deliver high quality, medical-related information that can help save lives.”

The SCIEX IVD-MS™ Immunosuppressants kit will work with the AB Sciex IVD-MS™ Analyzer, which is available for use in certain European countries.  Together, the kit and the analyzer will create a complete diagnostic solution for European hospitals and clinical laboratories, enabling simultaneous accurate quantitation of cyclosporine A, tacrolimus, sirolimus and everolimus in whole blood.  

AB Sciex has emerged as the new go-to provider of IVD kits in Europe for in vitro diagnostic purposes. The immunosuppressants kit, which is expected to ship in Europe in Q2, joins the company’s family of IVD kits in Europe.* Other kits include vitamin D analysis as well as an upcoming newborn screening kit, which was announced in a separate news release today.  

The technology used to perform this testing is mass spectrometry technology, which is an advanced analytical technique used for decades in the pharmaceutical industry, biomedical research and clinical research.  The benefits of this technology for customers include reliable results, comprehensive detection of compounds and metabolites, and fast, accurate quantitative measurement.  AB Sciex is a leader in transitioning clinical assays onto mass spectrometry.

AB Sciex is showcasing its immunosuppressants assay in its booth at Analytica this week in Munich, Germany.  Clinical experts from AB Sciex will also be on hand to answer questions about the company’s other IVD kits.  The clinical solutions will also be on display inside the Masstastic Voyage mobile laboratory parked at Analytica.  

*Will only be available in Europe, but not in every EU country. Contact a local AB SCIEX representative for more information. 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SCIEX, A*STAR’s BTI Launch Collaboration
Agreement aims to boost innovation of protein drugs that target new diseases and are safer for patients.
Wednesday, January 27, 2016
AB SCIEX and Dalton Collaborate to Advance ADC Analysis
Collaboration supports movement to develop targeted anti-body based therapies.
Friday, August 29, 2014
Scientific News
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Getting a Better Look at How HIV Infects and Takes Over its Host Cells
A new approach, developed by a team of researchers led by The Rockefeller University and The Aaron Diamond AIDS Research Center (ADARC), offers an unprecedented view of how a virus infects and appropriates a host cell, step by step.
Untangling Disease-Related Protein Misfolding
Work advances understanding of genetic forms of thrombosis, emphysema, cirrhosis of the liver, neurodegenerative diseases and inflammation, among others.
Developing a More Precise Seasonal Flu Vaccine
During the 2014-15 flu season, the poor match between the virus used to make the world’s vaccine stocks and the circulating seasonal virus yielded a vaccine that was less than 20 percent effective.
Fighting Cancer with Borrowed Immunity
A new step in cancer immunotherapy: researchers from the Netherlands Cancer Institute and University of Oslo/Oslo University Hospital show that even if one's own immune cells cannot recognize and fight their tumors, someone else's immune cells might.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
"Sunscreen" Gene May Guard Against Melanoma
USC-led study reveals that melanoma patients with deficient or mutant copies of the gene are less protected from harmful ultraviolet rays.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!